Highly Active Antiretroviral Therapy in Resource-Poor Settings

Journal Articles

June 21, 2003. British Medical Journal. Ruairí Brugha. Antiretroviral treatment in developing countries: the peril of neglecting private providers.
June 13, 2003. Journal of the International AIDS Society. Catherine Orrell, David R. Bangsberg, Motasim Badri, and Robin Wood. Adherence Is Not a Barrier to Successful Antiretroviral Therapy.
May 1, 2003. New England Journal of Medicine. Steven J. Reynolds, John G. Bartlett, Thomas C. Quinn, Chris Beyrer, and Robert C. Bollinger. Antiretroviral Therapy Where Resources Are Limited.
July, 2002. Journal of AIDS vol. 16(10): 1363 - 1370. Christian Laurenta; Ndella Diakhatéb; Ndeye Fatou Ngom Gueyeb; Mame Awa Touréb; Papa Salif Sowb; Mame Awa Fayeb; Mandoumbé Gueyec; Isabelle Laniècea; Coumba Touré Kaned; Florian Liégeoisa; Laurence Vergnea; Souleymane Mboupd; Salif Badianeb; Ibrahima Ndoyee; Eric Delaportea. Article Abstract. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.

NGO Documents

September 30, 2003. MSF, report on workshop. ARV Simplification for High-Prevalence Countries.
June 26, 2003. Kieth Alcom for Health Systems Trust. Private prescribing biggest risk for developing world drug resistance.
July 7, 2002. MSF press release. Waiting to treat AIDS is a crime: New data reasserts the feasibility of antiretroviral treatment in resource-poor settings. Governments still refuse to commit funds for life-extending medicines.
February 1, 2002. Health and Development Networks. Care, Treatment, and Support.
June 7, 2001. Comments of Andrew Natsios from USAID, punctuated with factual corrections from Paul Davis of Health GAP. USAID Administrator Natsios Press Remarks on HIV/AIDS in Africa.
No Date. Northwest Coalition for AIDS Treatment in Africa. Fact sheet for researchers and scientists.

World Health Organization

January, 2003. Kathy Attawell and Jackie Mundy for WHO and the UK's Department for International Development. Provision of antiretroviral therapy in resource-limited settings: a review of experience up to August 2003.

On April 22, 2002, the World Health Organization released the draft report Scaling Up Antiretroviral Therapy in Resource Limited Settings: Guidelines for a Public Health Approach. It sets guidelines for HIV treatment for poor countries. At this time, WHO includues 12 antiretrovirals on its Essential Drug List.

Full Report(pdf)
Executive Summary (pdf)
Press Release. WHO Takes Major Steps to Make HIV Treatment Accessible.
Donald McNeil for the New York Times. World Health Organization Announces New AIDS Guidelines.
Claire Nullis for the Associated Press. WHO includes antiretrovirals on essential medicine list.
Stephen Pincock for Reuters. WHO Gives HIV Drug Advice to Developing Countries.

2003. Toby Kasper, David Coetzee, Francoise Loius, Andrew Boulle, and Katherine Hildebrand for the Essential Drugs Monitor #32. Demystifying therapy in resource-poor settings.

News Stories

July 13, 2004. John Donnelly for the Boston Globe. Study finds AIDS drugs succeed in poor nations.
July 12, 2004. Nancy-Amelia Collins for the Voice of America. Medical Group Says AIDS Drugs Help Survival Rate in Developing Countries.
September 3, 2003. Donald G. McNeil for the New York Times. Africans outdo Americans in treatment compliance.
May 27, 2003. The Taipei Times. Poor South Africans prove they can use AIDS drugs.
May 25, 2003. Rory Carroll for the London Observer. Aids orphans'survival offers Africa hope: Ground-breaking treatment debunks drug firm myths.
February 12, 2003. Agence France Presse. AIDS Researchers Have Gained An Edge.
December 8, 2002. Anna Poppa for AIDS Map News. Antiretroviral adherence in resource-poor settings: Challenging the voices of doom.
July 16, 2002. Op-ed by David Beins in the Jakarta Post. Cheaper AIDS Drugs Not the Full Story.
July 12, 2002. David Brown for the Washington Post. Progress in AIDS Program in Haiti.

Misc.

No date. Joep M.A. Lange for the International Antiviral Therapy Evaluation Center. Access to antiretroviral therapy in resource-poor settings.
December 1, 2001. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, NIH. World AIDS Day Statement.

Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> CPTech Page on HIV/AIDS